GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Revium Recovery Inc (OTCPK:RVRC) » Definitions » EPS (Basic)

RVRC (Revium Recovery) EPS (Basic) : $ (TTM As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is Revium Recovery EPS (Basic)?

Revium Recovery's basic earnings per share (Basic EPS) for the six months ended in . 20 was $0.00. Revium Recovery does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Revium Recovery's EPS (Diluted) for the six months ended in . 20 was $0.00. Revium Recovery does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Revium Recovery's EPS without NRI for the six months ended in . 20 was $0.00. Revium Recovery does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Revium Recovery EPS (Basic) Historical Data

The historical data trend for Revium Recovery's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revium Recovery EPS (Basic) Chart

Revium Recovery Annual Data
Trend
EPS (Basic)

Revium Recovery Semi-Annual Data
EPS (Basic)

Revium Recovery EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Revium Recovery's Basic EPS for the fiscal year that ended in . 20 is calculated as


Revium Recovery's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revium Recovery  (OTCPK:RVRC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Revium Recovery EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Revium Recovery's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Revium Recovery Business Description

Traded in Other Exchanges
N/A
Address
10 HaMenofim Street, Herzliya, ISR, 4672561
Revium Recovery Inc is focused on developing cutting-edge nano-medicines to deliver treatment solutions for diseases with limited or no effective medical options. LipoVation has exclusive license rights to develop and market a novel technology related to Nano-Liposomal Particles (NLP) based medicines, including: novel formulation of a potent antibiotic which shows promise in combating several life-threatening antibiotic-resistant bacteria which currently have no available treatment, Novel adjuvant to cancer therapies, and novel immunization approach based on Liposomal Protein-Loaded Technology (LPLT).

Revium Recovery Headlines